Visitor Restrictions & COVID-19 Information

Visitor restrictions have been implemented at Franciscan locations across Indiana and Illinois. Many provider office locations have temporarily reduced hours of operation. 


Online Risk Assessment

Franciscan Health is offering a COVID-19 Risk Assessment and medical provider consultations to help direct you to the most appropriate care.



As the world responds to COVID-19, the Franciscan Health Foundation has created the Preparedness & Response Fund to support our response to this public health crisis.


See info in your area

I'm An Existing Patient

Since you have seen this provider before, please schedule your appointment using your Franciscan MyChart account.

Schedule In MyChart


I'm New to This Provider

As a new patient for this provider, please select an open appointment date and time to schedule your first visit.

Schedule Online

Account Support

New to MyChart? No activation code? Patients are issued a MyChart activation code during their office visit or can request a code online.

Sign Up Online Support FAQs
John R. Edwards MD, Bone Marrow Transplant
Primary Specialty

Bone Marrow Transplant

Secondary Specialties

Medical Oncology
Hematology and Medical Oncology

Provider Type

Independent - Not Employed by Franciscan Health

Board Certification
  • American Board of Pediatrics, Pediatrics
  • American Board of Pediatrics, Pediatric Hematology-Oncology

Accepting new patients





Indiana Blood & Marrow Transplantation

Indiana Blood & Marrow Transplantation, Indianapolis, IN

8111 S. Emerson Ave.
Cancer Center, Suite 105
Indianapolis, IN 46237
(317) 528-5500

Franciscan Health Cancer Center Indianapolis

Franciscan Health Cancer Center Indianapolis, Indianapolis, IN

8111 South Emerson Avenue
Suite 101
Indianapolis, IN 46237-8601
(317) 528-1420

Office Hours:
Monday 7:30 am - 5:00 pm
Tuesday 7:30 am - 5:00 pm
Wednesday 7:30 am - 5:00 pm
Thursday 7:30 am - 5:00 pm
Friday 7:30 am - 5:00 pm

Franciscan Health Indianapolis

Franciscan Health Indianapolis, Indianapolis, IN

8111 S. Emerson Ave.
Indianapolis, IN 46237
(317) 528-5000

  • Medical School
    University of Florida
  • Fellowship
    University of California - pediatric hematology/oncology and immunology/rheumatolgoy
    San Francisco, CA
  • Fellowship
    University of California - pediatric bone marrow transplant
    San Francisco, CA
  • Fellowship
    University of Florida - pediatric hematology/oncology
    Gainsville, FL
  • American Board of Pediatrics, Pediatrics
  • American Board of Pediatrics, Pediatric Hematology-Oncology

Research Publications

Dr. John Edwards is co-director of the stem cell transplantation program at Indiana Blood & Marrow Transplantation at Franciscan St. Francis Health.

Recent Publications include:

Ingersoll SB, Ahmad S, Stoltzzfus GP, Patel S, Radi MJ, Finkler NJ, Edwards JR, Holloway RW.  Functional Characterization of a Fluorescent  Highly Tumorigenic Ovarian Cancer Line to Test Cellular Therapy in Experimental Models.  International Journal of Gynecologic Oncology 2011.

Ingersoll SB, Ahmad S, Thoni N, Ahmed N, Monohan K and Edwards JR.  Targeting the II6-Pathway in Multiple Myeloma and Its Implications in Cancer-Associated Gene Hypermethylation.  Med Chem 2011 Sep;7(5):473-9.

Ingersoll SB, Stoltzfuz S, Merchant MH, Ahmad S, Ciomeck NA, Edwards C, Finkler NJ, Holloway RW, Edwards JR.  Evaluation of the Cytoxic Response Against Ovarian Cancer by Immune Effector Cells Isolated and Expanded from Healthy Donors vs. Patients or Cord Blood.  International Society for Cell Therapy (ISCT).  Rotterdam Netherlands.  May 18, 2011.

Bash R, Ingersoll SB, Sankpal UT, Ahmad S, Baker CH, Edwards JR, Holloway RW, Kaja S, Abdelrahim M.  Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and surviving through suppressing specificity protein transcription factors.  Gynecol Oncol 2011 Jul;122(1):163-70.  Epub 2011 Apr 15.

Crout CA, Koh LP, Gockerman JP, Moore JO, Decastro C, Long, GD, Diehl L, Gasparetto C, Niedzwiecki D, Edwards JR, Prosnitz L, Horwitz M, Chute J, Morris A, Davis P, Beaven A, Chao NJ, Ali-Osman F, Rizzieri DA.  Overcoming Drug Resistance in Mantle Cell Lymphoma Using a Combination of Dose Dense and Intense Therapy Cancer Investigation 2010 Jul;28(6):654-60.

Stiff PJ,Agovi MA, Antman KH, Blaise D, Camitta BM, Cairo MS, Childs RW, Edwards JR, Gale RP, Hale GA, Lazarus HM, Arora M.  High-Dose Chemotherapy with Blood or Bone Marrow Transplants for Rhabdomysarcoma.  Biol Blood and Marrow Transplant 2010 Apr;16(4):525-32.

Ingersoll SB, Ahmad S, Patel S, Edwards D, Patel D, Caballero L, Holloway RW, Edwards JR.  Functional characterization of a fluorescent highly tumorigenic cell line to use in an animal model of ovarian cancer. (abstract) Gynecologic Oncology 112(2009), S104-105.

Ingersoll SB, Patel S, Caballero L, Ahmad S, Edwards D, Holloway RW, Edwards JR.  Synergistic cytotoxicity of interferon alpha-2b and interleukin-2 in combination with PBMC against ovarian cancer:  development of an experimental model for cellular therapy.  Gynecologic Oncology 2009 Jan;112(1):192-98.

Gardner SL, Carreras J, Boudreau C, Camitta BM, Adams RH, Chen AR, Davies SM, Edwards JR, Groves AC, Hale GA, Lazarus HM, Arora M, Stiff PJ, Eapen M.  Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.  Bone Marrow Transplant 2008 May;41(10):867-72.

Ingersoll SB, Patel S, Monahan K, Caballero L, De Nardis SA, Ahmad S, Holloway RW, Edwards JR.  Synergistic Cytotoxicity of IFNa-2b and IL-2 in Combination with PBMC against Ovarian Cancer:  Development of an Experimental Model for Cellular Therapy.  Society of Gynecologic Oncologists Annual Meeting, Tampa FL March 2008.  



Please enter a valid Email Address

Get news, tips & health information sent directly to your inbox.